Features Partner Sites Information LinkXpress
Sign In
Advertise with Us


12 Nov 2016 - 16 Nov 2016
16 Nov 2016 - 19 Nov 2016

Modular Design of New Microplate Reader Encourages Modification and Upgrades

By BiotechDaily International staff writers
Posted on 25 Aug 2014
Print article
BioTek Instruments\' Synergy HTX Multi-Mode Microplate Reader
The Synergy HTX Multi-Mode Microplate Reader (Photo courtesy of BioTek)
Life science and biotech researchers now have available a state-of-the-art modular microplate reader with a wide range of capabilities from UV-visual absorbance to bottom fluorescence and luminescence.

The new BioTek Instruments, Inc. (Winooski, VT, USA) Synergy HTX Multi-Mode Microplate Reader is an entry-level multimode reader that automates UV-visual absorbance, fluorescence, luminescence, and AlphaScreen/AlphaLISA assays in 6- to 384-well microplates that can be delivered in samples as small as two microliters.

AlphaScreen (Amplified Luminescent Proximity Homogeneous Assay Screen) is versatile assay technology developed to measuring analytes using a homogenous protocol. This technology is an example of a bead-based proximity assay and was developed from a diagnostic assay technology known as LOCI (Luminescent Oxygen Channeling Assay) where singlet oxygen molecules, generated by high energy irradiation of donor beads, travel over a constrained distance of approximately 200 nanometers) to acceptor beads. This results in excitation of a cascading series of chemical reactions, ultimately causing generation of a chemiluminescent signal. Recently, the basic AlphaScreen technology was extended in that the chemistry of the acceptor bead was modified such that emitted light is more intense and spectrally defined, thereby markedly reducing interference from biological fluid matrices (such as trace hemolysis in serum and plasma). In this format, referred to as AlphaLISA, it provides an alternative technology to classical ELISA assays and is suitable for high throughput automated fluid dispensing and detection systems.

The Synergy HTX incorporates linear and orbital shaking and Four-Zone incubation to 50 degrees Celsius with condensation control to minimize plate lid condensation. These features, coupled with an available dual reagent dispenser, make the Synergy HTX an excellent platform for biochemical and cell-based applications such as nucleic acid quantification, cell growth and toxicity assays, kinetic ELISA, and inject/read assays.

The optional dual reagent injection system automates inject/read assays such as ion channels assays or flash luminescence assays (e.g., luciferase or ATP assays). The Synergy HTX’s modular design allows upgrading supported by BioTek’s Gen5 data analysis software for advanced reader control, data analysis, graphing, exporting, and reporting. Additionally, the instrument is compatible with BioTek’s Take3 Multi-Volume Microplate that measures up to 16 two microliter samples, two BioCells, or a standard cuvette for fast and simple multivolume, multisample analysis.

Related Links:

BioTek Instruments, Inc.

Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to BiotechDaily.com and get complete access to news and events that shape the world of biotechnology.
  • Free digital version edition of Bio Research International sent by email on regular basis
  • Free print version of Bio Research International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of Bio Research International in digital format
  • Free Bio Research International Newsletter sent every 2 weeks containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
Click here to Register


Drug Discovery

view channel
Image: Positive alpha-synuclein staining of a Lewy body from a patient with Parkinson\'s disease (Photo courtesy of Wikimedia Commons).

Bifunctional Dimer Drugs Prove Effective in Parkinson's Disease Yeast Model

A team of Canadian neurodegenerative disease researchers used a yeast model system to identify novel drug compounds that were able to block the misfolding of alpha- synuclein (AS) protein, which characterizes... Read more


view channel
Image: A space-filling model of the anticonvulsant drug carbamazepine (Photo courtesy of Wikimedia Commons).

Wastewater May Contaminate Crops with Potentially Dangerous Pharmaceuticals

Reclaimed wastewater used to irrigate crops is contaminated with pharmaceutical residues that can be detected in the urine of those who consumed such produce. Investigators at the Hebrew University... Read more


view channel

Collaborative Agreement to Aid in Setting Guidelines for Evaluating Potential Ebola Therapy

Cooperation between an Israeli biopharmaceutical company and medical branches of the US government is designed to set ground rules for continued evaluation of an experimental therapy for Ebola virus disease. RedHill Biopharma Ltd. (Tel Aviv, Israel), a biopharmaceutical company primarily focused on development and c... Read more
Copyright © 2000-2016 Globetech Media. All rights reserved.